HAB Pharmaceuticals
Heart Care1x15 Tablet
Prescription required
This medicine is dispensed only against a valid prescription from a registered medical practitioner. You’ll be asked to upload it at checkout, and a pharmacist reviews it before dispatch.
Prescription policyYou save ₹103.00 · Inclusive of all taxes
TELMISIGN TRIO tablet contains TELMISARTAN 40 mg, AMLODIPINE 5 mg and HYDROCHLOROTHIAZIDE 12.50 mg. Manufactured by HAB Pharmaceuticals in India and supplied in strip packing.
Available on order. The seller arranges supply before dispatch.
TELMISIGN TRIO is a tablet product marketed by HAB Pharmaceuticals that combines three active ingredients: TELMISARTAN 40 mg, AMLODIPINE 5 mg and HYDROCHLOROTHIAZIDE 12.50 mg. It is supplied as strips and manufactured in India. This entry provides basic product facts; for personalised medical guidance and instructions for use, please check the printed leaflet, consult the prescribing physician, or speak with a pharmacist.
TELMISIGN TRIO is a prescription tablet formulation from HAB Pharmaceuticals containing a combination of TELMISARTAN 40 mg, AMLODIPINE 5 mg and HYDROCHLOROTHIAZIDE 12.50 mg. It is presented in a strip packing and originates from India. This product description lists the composition and packaging only. For information about clinical use, dosing, contraindications, side effects and drug interactions, consult the product label, your prescribing doctor or a pharmacist. Do not make medication changes without professional advice.
Specific medical indications and approved uses for TELMISIGN TRIO are not provided in the vendor facts supplied here. For authoritative information on the medical conditions for which this combination is prescribed, please check the product label, the included patient information leaflet, or discuss with your prescribing physician or a pharmacist. They will provide guidance appropriate to the patient's medical history and treatment needs.
This listing describes the product composition — TELMISARTAN 40 mg, AMLODIPINE 5 mg and HYDROCHLOROTHIAZIDE 12.50 mg in a tablet form by HAB Pharmaceuticals. For information on the clinical benefits or expected outcomes of taking this medicine, refer to the product leaflet or discuss with your prescribing doctor or pharmacist. They can explain how this specific combination may fit into a treatment plan and what benefits may be expected for an individual patient.
TELMISARTAN 40 mg + AMLODIPINE 5 mg + HYDROCHLOROTHIAZIDE 12.50 mg
Follow the instructions on the prescription and the product label. Do not alter the dose, frequency, or duration without consulting your prescribing doctor. If the label or prescription is unclear, consult a pharmacist or the prescribing physician for clarification. Keep all medicine information leaflets for reference and contact a healthcare professional for any questions about missed doses or management of side effects.
This entry provides product composition and packaging only. For safety advice including contraindications, precautions, interactions, pregnancy and breastfeeding guidance, and monitoring requirements, please consult the product leaflet, your prescribing physician, or a pharmacist. Do not start, stop or change the dose of this medicine without professional medical advice. Keep the medicine out of reach of children, and inform healthcare providers of all other medicines and medical conditions before using this product. Specific side-effect information is not provided in this product fact sheet. Because TELMISIGN TRIO contains multiple active ingredients, possible adverse effects can vary. For a complete list of known side effects, consult the printed patient information leaflet included with the product, your prescribing doctor, or a pharmacist. Seek medical attention promptly if you experience severe or unusual symptoms after taking any medicine, and inform your healthcare provider about all medicines you are taking.
This product record contains composition and packaging information only. Warnings, contraindications and special precautions are not included here. For complete safety information relevant to your health status, consult the printed patient information leaflet, your prescribing doctor, or a pharmacist. Inform your healthcare provider about any allergies, other medical conditions, or concomitant medicines before using this product. Drug interaction details are not provided in the vendor facts available here. Since TELMISIGN TRIO contains multiple active substances, potential interactions with other medicines may exist. Before starting this medicine, show your healthcare provider or pharmacist a list of all prescription, over-the-counter and herbal products you take. For specific interaction data and advice on concomitant therapy, consult the product leaflet, your prescribing physician, or a pharmacist.
Storage instructions are not included in the vendor-supplied data. Check the product packaging and the patient information leaflet for storage conditions, expiry date and handling precautions. If the leaflet is missing or unclear, consult a pharmacist or the manufacturer. Store medicines out of reach of children, do not use past the printed expiry date, and keep the product in its original packaging unless otherwise instructed by a healthcare professional.
Returns and cancellations follow our return policy. Availability and prescription checks are confirmed at checkout.
TELMISIGN TRIO is listed as a medicine. Use it only as directed by a registered medical practitioner.
Yes. It is dispensed only against a valid prescription from a registered medical practitioner, which you upload at checkout.
Storage instructions are not included in the vendor-supplied data. Check the product packaging and the patient information leaflet for storage conditions, expiry date and handling precautions. If the leaflet is missing or unclear, consult a pharmacist or the manufacturer. Store medicines out of reach of children, do not use past the printed expiry date, and keep the product in its original packaging unless otherwise instructed by a healthcare professional.